Dessislava Lazarova
Sofia, Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targeted Sensitization of Leukemic T-cells to Anticancer Drugs by SIRT1 Agonist SRT-1720.
Journal: Anticancer research
Published: November 19, 2025
Multi-spin Redox Sensor for Electron Paramagnetic Resonance Studies of Tissue Redox State In Vivo: Validation of Data With a Conventional Spin Probe.
Journal: In vivo (Athens, Greece)
Published: May 18, 2025
An Electron Paramagnetic Resonance Study of the Superoxide-Scavenging and Redox-Modulating Effects of Lecithinized Superoxide Dismutase in the Bloodstream.
Journal: Molecules (Basel, Switzerland)
Published: March 16, 2025
Tolerable treatment of glioblastoma with redox-cycling 'mitocans': a comparative study in vivo.
Journal: Redox report : communications in free radical research
Published: August 15, 2023
Redox-Cycling "Mitocans" as Effective New Developments in Anticancer Therapy.
Journal: International journal of molecular sciences
Published: March 11, 2023
Over-Reduced State of Mitochondria as a Trigger of "β-Oxidation Shuttle" in Cancer Cells.
Journal: Cancers
Published: December 09, 2021
Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State.
Journal: Cancers
Published: December 06, 2021
A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.
Journal: Oxidative medicine and cellular longevity
Published: November 03, 2021
Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes.
Journal: Anticancer research
Published: October 06, 2021
Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide.
Journal: Anticancer research
Published: October 05, 2021
Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38.
Journal: Anticancer research
Published: July 09, 2020
Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
Journal: Oxidative medicine and cellular longevity
Published: February 19, 2020
Last Updated: 09/26/2026